The results of nearly 30 percent of clinical trials are not publicly disclosed within four years of completion, according to a study appearing in PLOS One.

Hiroki Saito from Carney Hospital in Massachusetts and Boston University's Christopher Gill analyzed some 400 randomly selected trials from the ClinicalTrials.gov database that were listed as being complete and calculated the time from them being finished to their publication.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.